Reminerlization Potential of GSE Gel versusCPP-ACP in Carious White Spot Lesions in Post Orthodontic Patients
1 other identifier
interventional
24
0 countries
N/A
Brief Summary
Assess the effectiveness of applying grape seed extract (GSE) gel versus casein phosphopeptide-amorphous calcium phosphate (MI) paste on remineralization of white spot lesion (WSLs) in post orthodontic patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2019
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 22, 2019
CompletedFirst Posted
Study publicly available on registry
May 29, 2019
CompletedStudy Start
First participant enrolled
October 3, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 6, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
May 10, 2020
CompletedMay 29, 2019
May 1, 2019
6 months
May 22, 2019
May 25, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Quantitative changes of white spot lesions
changes in fluorescence of white spot lesions will be evaluated after reminerlization by using diagnodent device by score (0-20).
evaluation of tooth surface changes at baseline and at 4, 12, and 24 weeks after starting treatment .
Study Arms (2)
Grape seeds extract
EXPERIMENTALEvery week the grape seeds extract (gel) put into the tray and apply it to the upper teeth of the participant.
Casein-phosphopeptide/amorphous-calcium phosphate
ACTIVE COMPARATORCPP-ACP paste apply to the teeth twice daily.
Interventions
CPP-ACP paste
Eligibility Criteria
You may qualify if:
- Presence of at least two WSLs on the labial surfaces of six maxillary anterior teeth that were not present before orthodontic therapy.
You may not qualify if:
- Severe or active periodontal disease.
- Patients had received therapeutic irradiation to the head and neck region.
- Patients had participated in a clinical trial within 6 months before commencement of this trial.
- Patients unable to return for recall appointments
- Presence of abnormal oral, medical, or mental condition (including any milk-related allergies or any medical condition involving kidneys or salivary glands).
- Presence of restorations or cavities in any anterior teeth or enamel hypoplasia, dental fluorosis, or intrinsic and extrinsic pigmentation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- pricipal investigator
Study Record Dates
First Submitted
May 22, 2019
First Posted
May 29, 2019
Study Start
October 3, 2019
Primary Completion
April 6, 2020
Study Completion
May 10, 2020
Last Updated
May 29, 2019
Record last verified: 2019-05